Neil Herskowitz - 02 Dec 2024 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Reporting relationship: Director
Issuer ticker: ATXI
Reported as of: 02 Dec 2024
Net transaction value: -$46
SEC form: 4
Accepted by SEC: 03 Dec 2024, 16:30:17 UTC
Prior SEC filing: 25 Sep 2024
Next SEC filing: 17 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ David Jin, Attorney-in-Fact

Key filing fact

Neil Herskowitz filed Form 4 for AVENUE THERAPEUTICS, INC. (ATXI) on 03 Dec 2024.

Key facts

This page summarizes Neil Herskowitz's Form 4 filing for AVENUE THERAPEUTICS, INC. (ATXI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Dec 2024, 16:30.

Change

Previous filing in this sequence was filed on 25 Sep 2024.
Current net transaction value: -$46.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATXI transaction

COMMON STOCK, PAR VALUE $0.0001

Sale

Transaction value: $46
Shares: -23
Change %: -19%
Price: $2.00
Shares after: 97
Date: 02 Dec 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the "Reverse Stock Split") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.